Biosyntia

Hørsholm, Denmark

Biosyntia is a biotech startup within synthetic biology and metabolic engineering.

$11.7M raised

Jul 2022

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Biosyntia raised?

Biosyntia has raised $11.7M in total funding. The most recent round was Series B. The last funding was announced in July 2022.

Who are Biosyntia's investors?

Biosyntia's investors include Novo Holdings, Sofinnova Partners, European Circular Bioeconomy Fund, Novo Ventures.

Where is Biosyntia headquartered?

Biosyntia is headquartered in Hørsholm, Denmark.

What does Biosyntia do?

Biosyntia is a biotech startup within synthetic biology and metabolic engineering.

What stage is Biosyntia at?

Biosyntia is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 6, 2022.

MLA

"Biosyntia — Funding & Investors." VCBacked, July 6, 2022, https://www.vcbacked.co/company/biosyntia. Accessed July 3, 2026.

APA

VCBacked. (2022). Biosyntia — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/biosyntia

Wikipedia (cite web)

{{cite web |title=Biosyntia — Funding & Investors |url=https://www.vcbacked.co/company/biosyntia |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 6, 2022.